Advances in schistosomiasis drug discovery based on natural products.

References

• Abd El Wahab WM, El-Badry AA, Mahmoud SS, El-Badry YA, El-Badry MA, Hamdy DA. 2021. Ginger (Zingiber officinale)-derived nanoparticles in Schistosoma mansoni infected mice: hepatoprotective and enhancer of etiological treatment. PLoS Negl Trop Dis. 15(5):e0009423.
   PubMed Web of Science ®Google Scholar
• Abe EM, Tambo E, Xue J, Xu J, Ekpo UF, Rollinson D, Yang K, Li SZ, Zhou XN. 2020. Approaches in scaling up schistosomiasis intervention towards transmission elimination in Africa: leveraging from the Chinese experience and lessons. Acta Trop. 208(July 2018):105379–105379. doi:10.1016/j.actatropica.2020.105379.
   PubMedGoogle Scholar
• Adekiya TA, Kondiah PP, Choonara YE, Kumar P, Pillay V. 2020. A review of nanotechnology for targeted anti-schistosomal therapy. Frontiers in Bioengineering and BiotechUhnology. 8:2296–4185.
   Web of Science ®Google Scholar
• Akachukwu I, Olubiyi OO, Kosisochukwu A, John MC, Justina NN. 2017. Structure-Based study of Natural products with anti-Schistosoma activity. Curr Comput-Aided Drug Des. 13(2):91–100. doi:10.2174/1573409913666170119114859.
   PubMed Web of Science ®Google Scholar
• Aleixo de Carvalho LSG, de Moraes RB, Silva Pinto J, de Faria Pinto PL, Pereira P, dos S O, Da Silva Filho AA. 2015. Schistosomicidal activity and docking of Schistosoma mansoni ATPDase 1 with licoflavone B isolated from glycyrrhizainflata (fabaceae). Exp Parasitol. 159:207–214. doi:10.1016/j.exppara.2015.09.015.
   PubMed Web of Science ®Google Scholar
• Aly HF, Mantawy MM. 2013. Efficiency of ginger (Zingiber officinale) against Schistosoma mansoni infection during host-parasite association. Parasitol Int. 62(4):380–389.
   PubMed Web of Science ®Google Scholar
• Ammar AI, Afifi AF, Essa A, Galal-Khallaf A, Mokhtar MM, Shehab-Eldeen S, Rady AA. 2020. Cucurbita pepo seed Oil induces microsatellite instability and tegumental damage to Schistosoma mansoni immature and adult worms In vitro. Infect Drug Resist. 13:3469–3484.
   PubMed Web of Science ®Google Scholar
• Aula OP, McManus DP, Jones MK, Gordon CA. 2021. Schistosomiasis with a focus on Africa. Tropical Medicine and Infectious Disease. 6(3):109–109.
   PubMedGoogle Scholar
• Banegas-Luna A-J, Cerón-Carrasco JP, Pérez-Sánchez H. 2018. A review of ligand-based virtual screening web tools and screening algorithms in large molecular databases in the age of big data. Future Med Chem. 10(22):2641–2658. doi:10.4155/fmc-2018-0076.
   PubMed Web of Science ®Google Scholar
• Batool M, Ahmad B, Choi S. 2019. A structure-based drug discovery paradigm. Int J Mol Sci. 20(11):2783–2783. doi:10.3390/ijms20112783.
   PubMed Web of Science ®Google Scholar
• Bender A, Cortes-Ciriano I. 2019. Artificial intelligence in drug discovery: what is realistic, what are illusions? part 2: a discussion of chemical and biological data. Drug Discovery Today Elseiver. 26(2):511–524. doi:10.1016/j.drudis.2020.11.037.
   Web of Science ®Google Scholar
• Bergquist R, Utzinger J, Keiser J. 2017. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? Infect Dis Poverty. 6(1):1–10. doi:10.1186/s40249-017-0286-2.
   PubMedGoogle Scholar
• Beshay EVN, Rady AA, Afifi AF, Mohamed AH. 2019. Schistosomicidal, antifibrotic and antioxidant effects of Cucurbita pepo L. seed oil and praziquantel combined treatment for Schistosoma mansoni infection in a mouse model. J Helminthol. 93(3):286–294. doi:10.1017/S0022149X18000317.
   PubMed Web of Science ®Google Scholar
• Bultum LE, Woyessa AM, Lee D. 2019. ETM-DB: Integrated Ethiopian traditional herbal medicine and phytochemicals database. BMC Complement Altern Med. 19(1):212–212. doi:10.1186/s12906-019-2634-1.
   PubMed Web of Science ®Google Scholar
• Caffrey CR, El-Sakkary N, Mäder P, Krieg R, Becker K, Schlitzer M, Drewry DH, Vennerstrom JL, Grevelding CG. 2019. Drug discovery and development for schistosomiasis. Neglected Tropical Diseases: Drug Discovery and Development. 12:187–225. doi:10.1002/9783527808656.ch8.
   Google Scholar
• Cheuka PM, Mayoka G, Mutai P, Chibale K. 2017. The role of natural products in drug discovery and development against neglected tropical diseases. Molecules. 22(1):58–58. doi:10.3390/molecules22010058.
   Web of Science ®Google Scholar
• Chisango TJ, Ndlovu B, Vengesai A, Nhidza AF, Sibanda EP, Zhou D, … Mduluza T. 2019. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity. BMC Infect Dis. 19(1):1–9.
   PubMedGoogle Scholar
• Cock IE, Selesho MI, Van Vuuren SF. 2018. A review of the traditional use of southern African medicinal plants for the treatment of selected parasite infections affecting humans. J Ethnopharmacol. 220:250–264.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Newman DJ. 2013. Natural products: a continuing source of novel drug leads. Biochimica et Biophysica Acta (BBA)-General Subjects. 1830(6):3670–3695.
   PubMed Web of Science ®Google Scholar
• De Rycker M, Baragaña B, Duce SL, Gilbert IH. 2018. Challenges and recent progress in drug discovery for tropical diseases. Nature. 559(7715):498–506. doi:10.1038/s41586-018-0327-4.
   PubMed Web of Science ®Google Scholar
• Dkhil MA, Khalil MF, Diab MS, Bauomy AA, Santourlidis S, Al-Shaebi EM, Al-Quraishy S. 2019. Evaluation of nanoselenium and nanogold activities against murine intestinal schistosomiasis. Saudi J Biol Sci. 26(7):1468–1472.
   PubMed Web of Science ®Google Scholar
• Duarte Galhardo de Albuquerque RD, Mahomoodally MF, Lobine D, Suroowan S, Rengasamy KR. 2020. Botanical products in the treatment and control of schistosomiasis: recent studies and distribution of active plant resources according to affected regions. Biology (Basel). 9(8):223–223. doi:10.3390/biology9080223.
   PubMedGoogle Scholar
• Durojaye OA, Nwanguma BC, Joshua PE, Ogidigo JO, Cosmas S, Asomadu RO, Obeta JN. 2019. Evaluation of 6-gingerol and its modified analogues as therapeutic candidates against Schistosoma mansoni phosphofructokinase. VacciMonitor. 28(1):38–47.
   Google Scholar
• Eissa MM, El-Azzouni MZ, El-Khordagui LK, Abdel Bary A, El-Moslemany RM, Abdel Salam SA. 2020. Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni. Parasites and Vectors. 13(1):1–12. doi:10.1186/s13071-020-04346-1.
   PubMed Web of Science ®Google Scholar
• El-derbawy1 MM, El WAEMS, Kholy1 IRB, S HS. 2019. A study of the potential therapeutic effect of ginger (Zingiber officinale) loaded nanoparticles on murine schistosomiasis mansoni. J Egypt Soc Parasitol. 49(1):123–128.
   Google Scholar
• El-Faham MH, Eissa MM, Igetei JE, Amer EI, Liddell S, El-Azzouni MZ, Doenhoff MJ. 2017. Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens. PLoS Negl Trop Dis. 11(8):1–26. doi:10.1371/journal.pntd.0005853.
   Web of Science ®Google Scholar
• El-Nour A, Mohamed F, Fadladdin Y. 2021. Anti-schistosomal activity of Zingiber officinale, piper nigrum, and coriandrum sativum aqueous plant extracts on hamsters infected with Schistosoma mansoni. J Parasitol Res. 2021.
   Web of Science ®Google Scholar
• El-Sameih MA, Hassan FA, Abed GH, Omar HEDM. 2017. Role Of ginger in the Treatment of Schistosoma mansoni infection a histopathological studies. Alexandria Journal of Veterinary Sciences. 52(1):198–204.
   Google Scholar
• Elujoba AA, Odeleye OM, Ogunyemi CM. 2005. Review traditional medicine development for medical and dental primary health care Delivery system in the orthodox medicine, as currently made available today in Nigeria (as in most African countries), so long as every nook and corner of our rural popu. African Ethnomedicines Network. 2:46–61.
   Google Scholar
• Eweas AF, Allam G, Abuelsaad AS, ALGhamdi AH, Maghrabi IA. 2013. Design, synthesis, anti-schistosomal activity and molecular docking of novel 8-hydroxyquinoline-5-sufonyl 1, 4-diazepine derivatives. Bioorg Chem. 46:17–25.
   PubMed Web of Science ®Google Scholar
• Fadladdin YAJ. 2021. Antischistosomal activity of Origanum majorana, Ziziphus spina-christi, and salvia fruticosa plant extracts on hamster infected with Schistosoma haematobium. BioMed Res Int. 2021.
   PubMed Web of Science ®Google Scholar
• Ferreira LG, Oliva G, Andricopulo AD. 2018. From medicinal Chemistry to human health: Current approaches to drug discovery for Cancer and Neglected Tropical diseases. Anais da Academia Brasileira de Ciensias. 90:645–661.
   PubMed Web of Science ®Google Scholar
• Fuss A, Mazigo HD, Mueller A. 2020. Malacological survey to identify transmission sites for intestinal schistosomiasis on ijinga island, mwanza, north-western Tanzania. Acta Trop. 203(April 2019):105289–105289. doi:10.1016/j.actatropica.2019.105289.
   PubMedGoogle Scholar
• Gemma S, Federico S, Brogi S, Brindisi M, Butini S, Campiani G. 2019. Dealing with schistosomiasis: Current drug discovery strategies. In Annual Reports in Medicinal Chemistry (1st ed., Vol. 53). Elsevier Inc. https://doi.org/10.1016/bs.armc.2019.06.002.
   Google Scholar
• Ghosh S, Das AK, Sarkar P, Sil PC. 2019. Oxidative stress in schistosomiasis, echinococcosis, and trypanosomiasis: a therapeutic approach. In: Discovery and development of therapeutics from Natural products against Neglected Tropical diseases. Kolkata: Elsevier; p. 219–239.
   Google Scholar
• Gönnert R, Andrews P. 1977. Praziquantel, a new broad-spectrum anti-schistosomal agent. ZeitschriftFür Parasitenkunde. 52(2):129–150. doi:10.1007/BF00389899.
   PubMed Web of Science ®Google Scholar
• Gouveia MJ, Brindley PJ, Gärtner F, Costa JM, Vale N. 2018. Drug repurposing for schistosomiasis: combinations of drugs or biomolecules. Pharmaceuticals. 11(1):15–15.
   Web of Science ®Google Scholar
• Gruessner BM, Cornet-Vernet L, Desrosiers MR, Lutgen P, Towler MJ, Weathers PJ. 2019. It is not just artemisinin: Artemisia sp. for treating diseases including malaria and schistosomiasis. Phytochem Rev. 18(6):1509–1527.
   PubMed Web of Science ®Google Scholar
• Guerra RA, Silva MP, Silva TC, Salvadori MC, Teixeira FS, De Oliveira RN, Rocha JA, Pinto PLS, De Moraes J. 2019. In vitro and in vivo studies of spironolactone as an anti-schistosomal drug capable of clinical repurposing. Antimicrob Agents Chemother. 63(3):1–11. doi:10.1128/AAC.01722-18.
   Web of Science ®Google Scholar
• Guidi A, Lalli C, Gimmelli R, Nizi E, Andreini M, Gennari N, Saccoccia F, Harper S, Bresciani A, Ruberti G. 2017. Discovery by organism-based high-throughput screening of new multi-stage compounds affecting Schistosoma mansoni viability, egg formation and production. PLoS Negl Trop Dis. 11(10):e0005994–e0005994. doi:10.1371/journal.pntd.0005994.
   PubMed Web of Science ®Google Scholar
• Guidi A, Lalli C, Perlas E, Bolasco G, Nibbio M, Monteagudo E, Bresciani A, Ruberti G. 2016. Discovery and Characterisation of novel anti-schistosomal properties of the anti-anginal drug, perhexiline and Its impact on Schistosoma mansoni male and female reproductive systems. PLoS Negl Trop Dis. 10(8):1–22. doi:10.1371/journal.pntd.0004928.
   Web of Science ®Google Scholar
• Hatherley R, Brown DK, Musyoka TM, Penkler DL, Faya N, Lobb KA, Tastan Bishop Ö. 2015. SANCDB: A South African natural compound database. J Cheminform. 7(1):29–29. doi:10.1186/s13321-015-0080-8.
   PubMedGoogle Scholar
• Hernandez HW, Soeung M, Zorn KM, Ashoura N, Mottin M, Andrade CH, Caffrey CR, de Siqueira-Neto JL, Ekins S. 2019. High-Throughput and Computational repurposing for Neglected diseases. Pharm Res. 36(2):27–27. doi:10.1007/s11095-018-2558-3.
   Web of Science ®Google Scholar
• Herrera Acevedo C, Scotti L, Feitosa Alves M, Formiga Melo Diniz MDF, Scotti MT. 2017. Computer-aided drug design using sesquiterpene lactones as sources of new structures with potential activity against infectious neglected diseases. Molecules. 22(1):79–79.
   PubMed Web of Science ®Google Scholar
• Kang N, Shen W, Gao H, Feng Y, Zhu W, Yang S, Liu Y, Xu Q, Yu D. 2018. Anti-schistosomal properties of hederacolchiside a1 isolated from Pulsatilla chinensis. Molecules. 23(6):1–16. doi:10.3390/molecules23061431.
   Web of Science ®Google Scholar
• Kefalidou AA, Nations U, Affairs S. 2016. Brief for GSDR – 2016 Update Sustainable drug development for Neglected Tropical Diseases. 1–6.
   Google Scholar
• Kiriiri GK, Njogu PM, Mwangi AN. 2020. Exploring different approaches to improve the success of drug discovery and development projects: a review. Futur J Pharm Sci. 6:27–27. doi:10.1186/s43094-020-00047-9.
   Web of Science ®Google Scholar
• Kuhn I, Kellenberger E, Said-Hassane F, Villa P, Rognan D, Lobstein A, Haiech J, Hibert M, Schuber F, Muller-Steffner H. 2010. Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD+ catabolizing enzyme. Bioorg Med Chem. 18(22):7900–7910. doi:10.1016/j.bmc.2010.09.041.
   PubMed Web of Science ®Google Scholar
• Kumar D. 2017. Software and web resources for computer-aided molecular software and web resources for computer-aided molecular modelling and drug discovery. March 2016. https://doi.org/10.1201/b19853-3.
   Google Scholar
• Lago EM, Silva MP, Queiroz TG, Mazloum SF, Rodrigues VC, Carnaúba PU, Pinto PL, Rocha JA, Ferreira LLG, Andricopulo AD, de Moraes J. 2019. Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis. EBioMedicine. 43:370–379. doi:10.1016/j.ebiom.2019.04.029.
   PubMed Web of Science ®Google Scholar
• Length F. 2017. Determination of bioactive constituents of Rauwolfia vomitoria afzel(asofeyeje) roots using gas chromatography-mass spectrometry (GC-MS) and Fourier transform infrared spectrometry (FT-IR). African Journal of Pharmacy and Pharmacology. 11(2):25–31. doi:10.5897/AJPP2016.4712.
   Google Scholar
• Lesser B. 2021. The Origin and Mechanism of Consuming and Administering Medicine. Dual diagnosis. orghttps://dualdiagnosis.org/drug-addiction/evolution-administering-consuming-drugs/.
   Google Scholar
• Lin X, Li X, Lin X. 2020. A review on applications of Computational methods in drug screening and design. Molecules. 25(6):1375–1375. doi:10.3390/molecules25061375.
   PubMed Web of Science ®Google Scholar
• Liu Y-X, Wu W, Liang Y-J, Jie Z-L, Wang H, Wang W, Huang Y-X. 2014. New uses for old drugs: The tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China. Molecules. 19:15058–15074.
   PubMed Web of Science ®Google Scholar
• Lombardo FC, Pasche V, Panic G, Endriss Y, Keiser J. 2019. Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni. Nat Protoc. 14(2):461–481.
   PubMed Web of Science ®Google Scholar
• Macalino SJY, Gosu V, Hong S, Choi S. 2015. Role of computer-aided drug design in modern drug discovery. Arch Pharmacal Res. 38(9):1686–1701.
   PubMed Web of Science ®Google Scholar
• Mafud AC, Silva MP, Monteiro DC, Oliveira MF, Resende JG, Coelho ML, … de Moraes J. 2016. Structural parameters, molecular properties, and biological evaluation of some terpenes targeting Schistosoma mansoni parasite. Chem-Biol Interact. 244:129–139.
   PubMed Web of Science ®Google Scholar
• Marxer M, Ingram K, Keiser J. 2012. Development of an in vitro drug screening assay using Schistosoma haematobium schistosomula. Parasit Vectors. 5(1):1–8.
   PubMedGoogle Scholar
• Mbereko A, Chimbari MJ, Manyangadze T, Mukaratirwa S. 2020. Knowledge and perceptions of schistosomiasis, a water-borne disease, in two semi-arid rural areas of South Africa (ndumo) and Zimbabwe (ntalale). Food and Waterborne Parasitology. 21:e00091–e00091.
   PubMedGoogle Scholar
• Melo-Filho CC, Dantas RF, Braga RC, Neves BJ, Senger MR, Valente WCG, Rezende-Neto JM, Chaves WT, Muratov EN, Paveley RA, et al. 2016. QSAR-Driven Discovery of novel chemical scaffolds active against Schistosoma mansoni. Journal of Chemical Information and Modelling. 56(7):1357–1372. doi:10.1021/acs.jcim.6b00055.
   PubMed Web of Science ®Google Scholar
• Mokbel KEDM, Baiuomy IR, Sabry AEHA, Mohammed MM, El-Dardiry MA. 2020. In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni. Sci Rep. 10(1):1–9.
   PubMed Web of Science ®Google Scholar
• Mølgaard P, Nielsen SB, Rasmussen DE, Drummond RB, Makaza N, Andreassen J. 2001. Anthelmintic screening of Zimbabwean plants traditionally used against schistosomiasis. J Ethnopharmacol. 74(3):257–264.
   PubMed Web of Science ®Google Scholar
• Moon S, Bermudez J, ‘t Hoen E. 2012. Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system? PLoS Med. 9(5):e1001218–e1001218. doi:10.1371/journal.pmed.1001218.
   PubMed Web of Science ®Google Scholar
• Moreira-Filho JT, Silva AC, Dantas RF, Gomes BF, Neto LRS, Brandao-Neto J, … Andrade CH. 2021. Schistosomiasis drug discovery in the Era of automation and Artificial intelligence. Front Immunol. 12:642383–642383.
   PubMed Web of Science ®Google Scholar
• Mortier J, Rakers C, Bermudez M, Murgueitio MS, Riniker S, Wolber G. 2015. The impact of molecular dynamics on drug design applications for the characterization of ligand-macromolecule complexes. Drug Discov Today. 20:20686–20702.
   Web of Science ®Google Scholar
• Mostafa OMS, Eid RA. 2011. Anti-schistosomal activity of ginger (Zingiber officinale) against Schistosoma mansoni harboured in C57 mice. 395–403. https://doi.org/10.1007/s00436-011-2267-x.
   Google Scholar
• Mtemeli FL, Walter I, Tinago T, Shoko R. 2021. An assessment of the molluscicidal potential of Cucurbita maxima seed extracts on biomphalaria pfeifferi and bulinus globosus snails. All Life. 14(1):244–255. DOI: 10.1080/26895293.2021.1901788.
   Web of Science ®Google Scholar
• Ndamba J, Nyazema N, Makaza N, Anderson C, Kaondera KC. 1994. Traditional herbal remedies used for the treatment of urinary schistosomiasis in Zimbabwe. J Ethnopharmacol. 42(2):125–132.
   PubMed Web of Science ®Google Scholar
• Neves BJ, Andrade CH, Cravo PVL. 2015. Natural products as leads in schistosome drug discovery. Molecules. 20(2):1872–1903. doi:10.3390/molecules20021872.
   PubMed Web of Science ®Google Scholar
• Neves BJ, Braga RC, Melo-Filho CC, Moreira-Filho JT, Muratov EN, Andrade CH. 2018. QSAR-based virtual screening: Advances and applications in drug discovery. Front Pharmacol. 9(NOV):1–7. doi:10.3389/fphar.2018.01275.
   PubMedGoogle Scholar
• Neves BJ, Dantas RF, Senger MR, Melo-Filho CC, Valente WCG, de Almeida ACM, Rezende-Neto JM, Lima EFC, Paveley R, Furnham N, et al. 2016a. Discovery of New anti-schistosomal hits by integration of QSAR-based virtual screening and high content screening. J Med Chem. 59(15):7075–7088. doi:10.1021/acs.jmedchem.5b02038.
   PubMed Web of Science ®Google Scholar
• Neves BJ, Muratov E, Machado RB, Andrade CH, Cravo PV. 2016b. Modern approaches to accelerate the discovery of new anti-schistosomal drugs. Expert Opin Drug Discovery. 11(6):557–567. doi:10.1080/17460441.2016.1178230.
   PubMed Web of Science ®Google Scholar
• Ngangoue MO, Ngameni B, Ambassa P, Chi GF, Wamba BEN, Ombito JO, … Ngadjui BT. 2020. A phenanthridine-6(5H)-one derivative and a lanostane-type triterpene with antibacterial properties from Anonidium mannii (oliv). engl. & diels (annonaceae). Nat Prod Res. 0(0):1–10. doi:10.1080/14786419.2020.1758094.
   Google Scholar
• Ntie-Kang F, Telukunta KK, Döring K, Simoben CV, Moumbock AAF, Malange YI, Njume LE, Yong JN, Sippl W, Günther S. 2017. NANPDB: A resource for Natural products from Northern African sources. J Nat Prod. 80(7): 2067–2076. doi:10.1021/acs.jnatprod.7b00283.
   PubMed Web of Science ®Google Scholar
• Nunes R, Campos P, Pinto R, Mioduski J, Santos R, Justus B, Padilha de Paula F, Klein T, Boscardin P, Corrêa S, et al. 2021. The promising antischistosomal activity of oleic acid-loaded polymeric nanocapsules for oral administration. Journal of Drug Delivery Science and Technology. 63:102429–102429. doi:10.1016/j.jddst.2021.102429.
   Web of Science ®Google Scholar
• Nunes RR, Costa MdS, Santos BdR, Fonseca ALd, Ferreira LS, Chagas RCR, Silva AMd, Varotti FdP, Taranto AG. 2016. Successful application of virtual screening and molecular dynamics simulations against antimalarial molecular targets. Memórias Do Instituto Oswaldo Cruz. 111(12):721–730. doi:10.1590/0074-02760160207.
   PubMed Web of Science ®Google Scholar
• Onasanya A, Bengtson M, Oladepo O, Engelen JV, Diehl JC, Author C. 2021. Rethinking the top-down approach to schistosomiasis control and elimination in sub-Saharan Africa. 9(February), 1–12. doi:10.3389/fpubh.2021.622809.
   Google Scholar
• Otarigho B. 2019. Structural, functional and docking analysis against Schistosoma mansoni dihydroorotate dehydrogenase for potential chemotherapeutic drugs. F1000Res. 8:651–651. doi:10.12688/f1000research.18904.1.
   Google Scholar
• Oyeyemi OT, de Jesus Jeremias W, Grenfell RFQ. 2020. Schistosomiasis in Nigeria: gleaning from the past to improve current efforts towards control. One Health. 11:10013–100183. doi:10.1016/j.onehlt.2020.100183.
   Web of Science ®Google Scholar
• Panic G, Duthaler U, Speich B, Keiser J. 2014. Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol 4:185–200.
   Web of Science ®Google Scholar
• Pasche V, Laleu B, Keiser J. 2019. Early antischistosomal leads identified from in vitro and in vivo screening of the Medicines for Malaria Venture pathogen Box. ACS Infect Dis. 5(1):102–110. doi:10.1021/acsinfecdis.8b00220.
   PubMed Web of Science ®Google Scholar
• Pereira C, Saye M, Reigada C, Silber A, Labadie G, Miranda M, & Valera-Vera E. 2020. Computational approaches for drug discovery against trypanosomatid-caused diseases. Parasitology. 147(6):611–633. doi:10.1017/S0031182020000207.
   PubMed Web of Science ®Google Scholar
• Prieto-Martínez FD, López-López E, Juárez-Mercado KE, Medina-Franco JL. 2019. Computational drug design methods—current and future perspectives. In: In silico drug design. Veracruz: Academic Press; p. 19–44.
   Google Scholar
• Roquini DB, Cogo RM, Mengarda AC, Mazloum SF, Morais CS, Xavier RP, Salvadori MC, Teixeira FS, Ferreira LE, Pinto PL, et al. 2019. Promethazine exhibits antiparasitic properties In vitro and reduces worm burden, Egg production, hepatomegaly, and splenomegaly in a schistosomiasis animal model daniel. American Society for Microbiology. 63(12):1–10.
   Google Scholar
• Sanderson L, Bartlett A, Whitfield P. 2002. In vitro and in vivo studies on the bioactivity of a ginger (Zingiber officinale) extract towards adult schistosomes and their egg production. J Helminthol. 76(3):241–247. doi:10.1079/JOH2002116.
   PubMed Web of Science ®Google Scholar
• Schultz MD, Dadali T, Jacques SA, Muller-Steffner H, Foote JB, Sorci L, … Lund FE. 2020. Inhibition of the NAD salvage pathway in schistosomes impairs metabolism, reproduction, and parasite survival. PLoS Pathog. 16(5):e1008539–e1008539.
   PubMed Web of Science ®Google Scholar
• Selvaraj C, Chandra I, Kumar Singh S. 2021. Artifcial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries. Mol Diversity. doi:10.1007/s11030-021-10326-z.
   PubMed Web of Science ®Google Scholar
• Shelar DB, Shirote PJ. 2011. Natural product in drug discovery: back to future. Biomedical & Pharmacology Journal. 4(1):141–141.
   Google Scholar
• Singh R, Pandey PN. 2015. Molecular docking and molecular dynamics study on SmHDAC1 to identify potential lead compounds against schistosomiasis. Mol Biol Rep. 42(3):689–698.
   PubMed Web of Science ®Google Scholar
• Sorokina M, Steinbeck C. 2020. Review on natural products databases: where to find data in 2020. J Cheminform. 12(1):1–51.
   PubMed Web of Science ®Google Scholar
• Sparg SG, Van Staden J, Jäger AK. 2000. Efficiency of traditionally used South African plants against schistosomiasis. J Ethnopharmacol. 73(1-2):209–214.
   PubMed Web of Science ®Google Scholar
• Stein EM, Machado LP, Roffato HK, Miyasato PA, Nakano E, Colepicolo P, Andreguetti DX. 2015. Antischistosomal activity from Brazilian marine algae. Revista Brasileira de Farmacognosia. 25:663–667.
   Google Scholar
• Stein EM, Tajú SG, Miyasato PA, de Freitas RP, Tallarico LDF, Dos Santos GS, … Nakano E. 2021. The prospective use of Brazilian marine macroalgae in schistosomiasis control. Mar Drugs. 19(5):234–234.
   PubMed Web of Science ®Google Scholar
• Süntar I. 2020. Importance of ethnopharmacological studies in drug discovery: role of medicinal plants. Phytochem Rev. 19(5):1199–1209. doi:10.1007/s11101-019-09629-9.
   Web of Science ®Google Scholar
• Tavares NC, de Aguiar PHN, Gava SG, Oliveira G, Mourão MM. 2016. Schistosomiasis: setting routes for drug discovery. Special Topics in Drug Discovery. Chapter 5:116–24. doi:10.5772/65386.
   Google Scholar
• Tekwu EM, Bosompem KM, Anyan WK, Appiah-Opong R, Owusu KBA, Tettey MD, … Nyarko AK. 2017. In vitro assessment of Anthelmintic activities of Rauwolfia vomitoria (apocynaceae) stem bark and roots against parasitic stages of Schistosoma mansoni and cytotoxic study. J Parasitol Res. 2017:2090–0023. doi:10.1155/2017/2583969.
   Google Scholar
• Thomas CM, Timson DJ. 2020. The mechanism of action of praziquantel: can new drugs exploit similar mechanisms? Curr Med Chem. 27(5):676–696.
   PubMed Web of Science ®Google Scholar
• Torini JR, Romanello L, Batista FAH, Serrão VHB, Faheem M, Zeraik AE, … Pereira HDM. 2018. The molecular structure of Schistosoma mansoni PNP isoform 2 provides insights into the nucleoside selectivity of PNPs. PloS one. 13(9):e0203532–e0203532.
   PubMed Web of Science ®Google Scholar
• ToussiMatchi JL, TchamoNoungoue D, Kuhn I, Boissier J, Tchouankeu JC, Nothisen M, Wagner A. 2020. Manniindole, an indole derivative from the roots of Anonidium mannii and combined antischistosomal and enzymatic activities. Nat Prod Res. 0(0):1–9. doi:10.1080/14786419.2020.1824227.
   Google Scholar
• Tung C. 2014. Public Databases of Plant Natural Products for Computational Drug Discovery. 191–196.
   Google Scholar
• Wang L, Ding J, Pan L, Cao D, Jiang H, Ding X. 2019. Artificial intelligence facilitates drug design in the big data era. Chemom Intell Lab Syst. 194:article 103850–103850.
   Web of Science ®Google Scholar
• Weng HB, Chen HX, Wang MW. 2018. Innovation in neglected tropical disease drug discovery and development. Infect Dis Poverty. 7(1):1–9.
   PubMed Web of Science ®Google Scholar
• Wilson GL, Lill MA. 2011. Integrating structure-based and ligand-based approaches for computational drug design. Future Med. Chem. 3(6):735–750.
   PubMed Web of Science ®Google Scholar
• Xiao S, Chollet J, Utzinger J, Matile H, Mei J, Tanner M. 2001. Artemether administered together with haemin damages schistosomes in vitro. Trans R Soc Trop Med Hyg 95:67–71.
   PubMed Web of Science ®Google Scholar
• Xu X, Huang M, Zou X. 2018. Docking-based inverse virtual screening: methods, applications, and challenges. Biophys Rep. 4:1–16. doi:10.1007/s41048-017-0045-8.
   PubMedGoogle Scholar
• Yousif F, Hifnawy MS, Soliman G, Boulos L, Labib T, Mahmoud S, … El-Menshawi BS. 2007. Large-scale in vitro. screening of Egyptian native and cultivated plants for schistosomicidal activity. Pharm Biol. 45(6):501–510.
   Web of Science ®Google Scholar
• Zorn KM, Sun S, Mcconnon CL, Ma K, Chen EK, Foil DH, Lane TR, Liu LJ, El-Sakkary N, Skinner DE, et al. 2021. A machine learning strategy for drug discovery identifies anti-schistosomal small molecules. ACS Infect Dis. 7(2):406–420. doi:10.1021/acsinfecdis.0c00754.
   PubMed Web of Science ®Google Scholar